These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Temsirolimus in metastatic chromophobe renal cell carcinoma after interferon and sorafenib therapy. Paule B; Brion N Anticancer Res; 2011 Jan; 31(1):331-3. PubMed ID: 21273619 [TBL] [Abstract][Full Text] [Related]
64. Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies. Alaghehbandan R; Trpkov K; Tretiakova M; Luis AS; Rogala JD; Hes O Adv Anat Pathol; 2021 Jan; 28(1):8-20. PubMed ID: 33021507 [TBL] [Abstract][Full Text] [Related]
65. Smoking enhanced the expression of c-kit in chromophobe renal cell carcinoma. Jiang J; Yang L; Chen M; Xiao F; Zeng Y; Zhu H; Li Y; Liu L Tob Induc Dis; 2023; 21():126. PubMed ID: 37808589 [TBL] [Abstract][Full Text] [Related]
66. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas. Zigeuner R; Ratschek M; Langner C BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785 [TBL] [Abstract][Full Text] [Related]
67. [Diagnosis and Treatment of 126 Cases of Chromophobe Renal Cell Carcinoma]. Bai HS; Wang D; Wen L; Shou JZ; Li CL; Xing NZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Apr; 43(2):247-252. PubMed ID: 33966705 [TBL] [Abstract][Full Text] [Related]
68. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Linehan WM; Ricketts CJ Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395 [TBL] [Abstract][Full Text] [Related]
69. Endocytosis-Mediated Replenishment of Amino Acids Favors Cancer Cell Proliferation and Survival in Chromophobe Renal Cell Carcinoma. Xiao Y; Rabien A; Buschow R; Amtislavskiy V; Busch J; Kilic E; Villegas SL; Timmermann B; Schütte M; Mielke T; Yaspo ML; Jung K; Meierhofer D Cancer Res; 2020 Dec; 80(24):5491-5501. PubMed ID: 33115803 [TBL] [Abstract][Full Text] [Related]
70. Imaging Mass Spectrometry Is an Accurate Tool in Differentiating Clear Cell Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma: A Proof-of-concept Study. Lu HC; Patterson NH; Judd AM; Reyzer ML; Sehn JK J Histochem Cytochem; 2020 Jun; 68(6):403-411. PubMed ID: 32466698 [TBL] [Abstract][Full Text] [Related]
71. Chromophobe renal cell carcinoma: New genetic and metabolic insights. Zhang L; Henske EP Urol Oncol; 2020 Aug; 38(8):678-681. PubMed ID: 32444178 [TBL] [Abstract][Full Text] [Related]
72. PD-L2: A prognostic marker in chromophobe renal cell carcinoma? Erlmeier F; Weichert W; Autenrieth M; Wiedemann M; Schrader AJ; Hartmann A; Ivanyi P; Steffens S Med Oncol; 2017 May; 34(5):71. PubMed ID: 28353093 [TBL] [Abstract][Full Text] [Related]
73. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases]. Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881 [TBL] [Abstract][Full Text] [Related]
74. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study. Kolar J; Llaurado AF; Ulamec M; Skenderi F; Perez-Montiel D; Alvarado-Cabrero I; Bulimbasic S; Sperga M; Tretiakova M; Osunkoya AO; Rogala J; Comperat E; Gal V; Dunatov A; Pivovarcikova K; Michalova K; Vesela AB; Slisarenko M; Strakova AP; Pitra T; Hora M; Michal M; Alaghehbandan R; Hes O Ann Diagn Pathol; 2022 Oct; 60():151978. PubMed ID: 35609473 [TBL] [Abstract][Full Text] [Related]
75. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
76. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma. Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694 [TBL] [Abstract][Full Text] [Related]
78. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis. Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788 [TBL] [Abstract][Full Text] [Related]
79. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590 [TBL] [Abstract][Full Text] [Related]